115 related articles for article (PubMed ID: 14572865)
1. 3-Benzyl-2H-1,3-benzoxazine-2,4(3H)-diones, a new group of antimycobacterial compounds against potentially pathogenic strains.
Waisser K; Perina M; Kunes J; Klimesová V; Kaustová J
Farmaco; 2003 Nov; 58(11):1137-49. PubMed ID: 14572865
[TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones].
Waisser K; Gregor J; Holý P; Kubicová L; Klimesová V; Kaustová J
Ceska Slov Farm; 2001 May; 50(3):148-52. PubMed ID: 11394023
[TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial 3-aryl-2H-1,3-benzoxazine-2,4(3H)-diones.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Palát K; Kaustová J; Danse HM; Möllmann U
Pharmazie; 2003 Feb; 58(2):83-94. PubMed ID: 12641321
[TBL] [Abstract][Full Text] [Related]
4. A note to the biological activity of benzoxazine derivatives containing the thioxo group.
Waisser K; Petrlíková E; Perina M; Klimesová V; Kunes J; Palát K; Kaustová J; Dahse HM; Möllmann U
Eur J Med Chem; 2010 Jul; 45(7):2719-25. PubMed ID: 20226572
[TBL] [Abstract][Full Text] [Related]
5. New groups of antimycobacterial agents: 6-chloro-3-phenyl-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 6-chloro-3-phenyl-2H-1,3-benzoxazine-2,4(3H)-dithiones.
Waisser K; Gregor J; Kubicová L; Klimesová V; Kunes J; Machácek M; Kaustová J
Eur J Med Chem; 2000; 35(7-8):733-41. PubMed ID: 10960190
[TBL] [Abstract][Full Text] [Related]
6. Relationships between the chemical structure of antimycobacterial substances and their activity against atypical strains. Part 14: 3-Aryl-6,8-dihalogeno-2H-1,3-benzoxazine-2,4(3H)-diones.
Waisser K; Hladuvková J; Gregor J; Rada T; Kubicová L; Klimesová V; Kaustová J
Arch Pharm (Weinheim); 1998 Jan; 331(1):3-6. PubMed ID: 9507695
[TBL] [Abstract][Full Text] [Related]
7. Influence of the replacement of the oxo function with the thioxo group on the antimycobacterial activity of 3-aryl-6,8-dichloro-2H-1,3-benzoxazine-2,4(3H)-diones and 3-arylquinazoline-2,4(1H,3H)-diones.
Waisser K; Gregor J; Dostál H; Kunes J; Kubicová L; Klimesová V; Kaustová J
Farmaco; 2001 Oct; 56(10):803-7. PubMed ID: 11718275
[TBL] [Abstract][Full Text] [Related]
8. Highly active potential antituberculotics: 3-(4-alkylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dihiones substituted in ring-B by halogen.
Waisser K; Matyk J; Kunes J; Dolezal R; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2008 Dec; 341(12):800-3. PubMed ID: 19006090
[TBL] [Abstract][Full Text] [Related]
9. Highly active antimycobacterial derivatives of benzoxazine.
Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
[TBL] [Abstract][Full Text] [Related]
10. [New groups of potential antitubercular agents: 3-(4-ethoxythiocarbonylphenyl)-2-H-benzoxazin-2,4(3H)-diones and 3-(4-ethoxythiocarbonylphenyl)-4-thioxy-2H-benzoxazin-2(3H)-ones].
Waisser K; Holý P; Bures O; Kunes J; Kaustová J
Ceska Slov Farm; 2003 Jan; 52(1):42-7. PubMed ID: 12685334
[TBL] [Abstract][Full Text] [Related]
11. Effect of substitution on the antimycobacterial activity of 2-(substituted benzyl)sulfanyl benzimidazoles, benzoxazoles, and benzothiazoles--a quantitative structure-activity relationship study.
Pytela O; Klimešová V
Chem Pharm Bull (Tokyo); 2011; 59(2):179-84. PubMed ID: 21297296
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
13. Antimycobacterial N-pyridinylsalicylamides, isosters of salicylamides.
Waisser K; Drazková K; Kunes J; Klimesová V; Kaustová J
Farmaco; 2004 Aug; 59(8):615-25. PubMed ID: 15262531
[TBL] [Abstract][Full Text] [Related]
14. Heterocyclic isosters of antimycobacterial salicylanilides.
Matyk J; Waisser K; Drazková K; Kunes J; Klimesová V; Palát K; Kaustová J
Farmaco; 2005 May; 60(5):399-408. PubMed ID: 15910812
[TBL] [Abstract][Full Text] [Related]
15. 1-Aryl-5-benzylsulfanyltetrazoles, a new group of antimycobacterial compounds against potentially pathogenic strains.
Waisser K; Adamec J; Dolezal R; Kaustová J
Folia Microbiol (Praha); 2005; 50(3):195-7. PubMed ID: 16295656
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antimycobacterial and isocitrate lyase inhibition properties of novel 2-methoxy-2'-hydroxybenzanilides, their thioxo analogues and benzoxazoles.
Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Wsól V; Vinšová J
Eur J Med Chem; 2012 Oct; 56():108-19. PubMed ID: 22960697
[TBL] [Abstract][Full Text] [Related]
17. The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Palát K; Kaustová J
Arch Pharm (Weinheim); 2007 May; 340(5):264-7. PubMed ID: 17516578
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.
Kazimierczuk Z; Andrzejewska M; Kaustova J; Klimesova V
Eur J Med Chem; 2005 Feb; 40(2):203-8. PubMed ID: 15694655
[TBL] [Abstract][Full Text] [Related]
19. Heterocyclic benzazole derivatives with antimycobacterial in vitro activity.
Kocí J; Klimesová V; Waisser K; Kaustová J; Dahse HM; Möllmann U
Bioorg Med Chem Lett; 2002 Nov; 12(22):3275-8. PubMed ID: 12392731
[TBL] [Abstract][Full Text] [Related]
20. High active potential antimycobacterial agents against Mycobacterium avium.
Karel W; Jiří K; Jiřina S
Ceska Slov Farm; 2012 Jun; 61(3):127-9. PubMed ID: 22913828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
